• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺素E1治疗勃起功能障碍的疗效与副作用

Efficiency and side effects of prostaglandin E1 in the treatment of erectile dysfunction.

作者信息

Waldhauser M, Schramek P

机构信息

Department of Urology, University of Vienna, Austria.

出版信息

J Urol. 1988 Sep;140(3):525-7. doi: 10.1016/s0022-5347(17)41709-5.

DOI:10.1016/s0022-5347(17)41709-5
PMID:3045341
Abstract

The efficiency and side effects of a single dose of intracorporeally applied prostaglandin E1 (20 mcg.) in inducing penile erection were examined. In addition, the effect of this dose of prostaglandin E1 was compared to the effect of 7.5 mg. papaverine plus 0.25 mg. phentolamine in a double-blind, crossover designed study. We tested twice 12 men 52.9 +/- 7.6 years old (mean +/- standard deviation) with erectile dysfunction. On 1 occasion the subjects received 20 mcg. prostaglandin E1 and on the other they received 7.5 mg. papaverine and 0.25 mg. phentolamine. At this dosage prostaglandin E1 was most effective in inducing artificial penile erection (11 of 12 patients). However, 75 per cent of the subjects reported burning sensations during the entire period of erection and in 1 prostaglandin E1 treatment resulted in a sustained erection. At the doses used, prostaglandin E1 was more effective in inducing penile erection than papaverine plus phentolamine (11 versus 6 patients). Intracavernous injection of prostaglandin E1 is a potent tool for artificial penile erection and warrants precise examination for its potential clinical use.

摘要

研究了单剂量经体内应用前列腺素E1(20微克)诱导阴茎勃起的有效性和副作用。此外,在一项双盲、交叉设计的研究中,将该剂量前列腺素E1的效果与7.5毫克罂粟碱加0.25毫克酚妥拉明的效果进行了比较。我们对12名年龄为52.9±7.6岁(平均值±标准差)的勃起功能障碍男性进行了两次测试。受试者一次接受20微克前列腺素E1,另一次接受7.5毫克罂粟碱和0.25毫克酚妥拉明。在此剂量下,前列腺素E1在诱导人工阴茎勃起方面最有效(12名患者中有11名)。然而,75%的受试者在整个勃起期间报告有烧灼感,在1例中,前列腺素E1治疗导致了持续性勃起。在所使用的剂量下,前列腺素E1在诱导阴茎勃起方面比罂粟碱加酚妥拉明更有效(分别为11例和6例患者)。海绵体内注射前列腺素E1是诱导人工阴茎勃起的有效手段,值得对其潜在临床应用进行精确研究。

相似文献

1
Efficiency and side effects of prostaglandin E1 in the treatment of erectile dysfunction.前列腺素E1治疗勃起功能障碍的疗效与副作用
J Urol. 1988 Sep;140(3):525-7. doi: 10.1016/s0022-5347(17)41709-5.
2
Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison.前列腺素E1与酚妥拉明/罂粟碱治疗勃起功能障碍的双盲比较
J Urol. 1989 Mar;141(3):549-50. doi: 10.1016/s0022-5347(17)40889-5.
3
Objective double-blind evaluation of erectile function with intracorporeal papaverine in combination with phentolamine and/or prostaglandin E1.采用双盲法评估阴茎海绵体内注射罂粟碱联合酚妥拉明和/或前列腺素E1对勃起功能的影响。
J Urol. 1992 Oct;148(4):1181-3. doi: 10.1016/s0022-5347(17)36853-2.
4
Calcitonin-gene-related peptide: a possible role in human penile erection and its therapeutic application in impotent patients.降钙素基因相关肽:在人类阴茎勃起中的可能作用及其在阳痿患者中的治疗应用。
J Urol. 1991 Oct;146(4):1010-4. doi: 10.1016/s0022-5347(17)37989-2.
5
Intracavernous injection of prostaglandin E1 in combination with papaverine: enhanced effectiveness in comparison with papaverine plus phentolamine and prostaglandin E1 alone.海绵体内注射前列腺素E1与罂粟碱联合使用:与单独使用罂粟碱加酚妥拉明及单独使用前列腺素E1相比,效果更佳。
J Urol. 1991 Jan;145(1):56-9. doi: 10.1016/s0022-5347(17)38246-0.
6
A prospective double-blind trial of intracorporeal papaverine versus prostaglandin E1 in the treatment of impotence.一项关于体内注射罂粟碱与前列腺素E1治疗阳痿的前瞻性双盲试验。
J Urol. 1989 Mar;141(3):551-3. doi: 10.1016/s0022-5347(17)40890-1.
7
Prostaglandin E1 therapy for impotence, comparison with papaverine.前列腺素E1治疗阳痿,与罂粟碱的比较。
J Urol. 1990 Jan;143(1):57-9. doi: 10.1016/s0022-5347(17)39864-6.
8
Double-blind, cross-over study comparing prostaglandin E1 and papaverine in patients with vasculogenic impotence.比较前列腺素E1和罂粟碱治疗血管性阳痿患者的双盲交叉研究。
Urology. 1991 Jun;37(6):516-8. doi: 10.1016/0090-4295(91)80314-w.
9
Comparison of Alprostadil (Caverject) and a combination of vasoactive drugs as local injections for the treatment of erectile dysfunction.前列地尔(凯威捷)与血管活性药物联合局部注射治疗勃起功能障碍的比较。
Int Urol Nephrol. 1998;30(5):617-20. doi: 10.1007/BF02550556.
10
[Intracavernous injection of vasoactive drugs for treating erectile impotence].[海绵体内注射血管活性药物治疗勃起功能障碍]
Hinyokika Kiyo. 1988 Feb;34(2):301-4.

引用本文的文献

1
Comparison of Alprostadil (Caverject) and a combination of vasoactive drugs as local injections for the treatment of erectile dysfunction.前列地尔(凯威捷)与血管活性药物联合局部注射治疗勃起功能障碍的比较。
Int Urol Nephrol. 1998;30(5):617-20. doi: 10.1007/BF02550556.
2
Colour penile Doppler ultrasonography with intraurethral prostaglandin-E2: preliminary results.阴茎彩色多普勒超声联合尿道内前列腺素E2:初步结果
Int Urol Nephrol. 1997;29(6):667-71. doi: 10.1007/BF02552184.
3
Intracavernous pharmacotherapy.海绵体内药物治疗。
World J Urol. 1997;15(1):71-7. doi: 10.1007/BF01275160.
4
Intracavernous alprostadil. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in erectile dysfunction.海绵体内注射前列地尔。其药效学、药代动力学特性及在勃起功能障碍中的治疗潜力综述。
Drugs Aging. 1996 Jan;8(1):56-74. doi: 10.2165/00002512-199608010-00009.
5
New developments in the diagnosis and treatment of impotence.阳痿诊断与治疗的新进展。
West J Med. 1996 Jan;164(1):54-61.
6
Prostaglandin E1 in the medical management of erectile dysfunction in a genito-urinary medicine clinic.前列腺素E1在泌尿生殖医学门诊勃起功能障碍治疗中的应用
Ulster Med J. 1994 Apr;63(1):18-22.
7
Intracavernous prostaglandin E1 in erectile dysfunction.阴茎海绵体内注射前列腺素E1治疗勃起功能障碍
Clin Investig. 1994 Jan;72(2):139-49. doi: 10.1007/BF00184593.
8
Dose-dependent effect and side-effect of prostaglandin E1 in erectile dysfunction.前列腺素E1在勃起功能障碍中的剂量依赖性效应及副作用
Br J Clin Pharmacol. 1989 Nov;28(5):567-71. doi: 10.1111/j.1365-2125.1989.tb03543.x.